
Indentification and Management of Tyrosine Kinase Inhibitors (TKIs) Toxicities
Josephine Previlon, MPAS, PA-C

Current Status and Future Potential of Proton Therapy
Tim Williams, MD | Current Status and Future Potential of Proton Therapy

Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?
Jonathan Kaufman, MD

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Mohamed Kharfan-Dabaja, MD